SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
SiriusPoint Ltd. (SPNT) trades at a trailing P/E of 5.9, forward P/E of 8.7. Trailing earnings yield is 17.03%, forward earnings yield 11.44%. PEG 0.03 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (90/100, Pass) — P/E is below market average (5.9); PEG ≤ 1.0 — Peter Lynch undervalued (0.03); analyst target implies upside (+10.9%); earnings yield beats bond yields (17.03%).
- PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 17.03% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $25.00 (+10.9% upside) — modest upside expected.
Overall SharesGrow Score: 75/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SPNT
Valuation Multiples
P/E (TTM)5.9
Forward P/E8.7
PEG Ratio0.03
Forward PEG0.90
P/B Ratio1.09
P/S Ratio0.85
EV/EBITDA4.0
Per Share Data
EPS (TTM)$3.94
Forward EPS (Est.)$2.58
Book Value / Share$-63.26
Revenue / Share$27.30
FCF / Share$0.82
Yields & Fair Value
Earnings Yield17.03%
Forward Earnings Yield11.44%
Dividend Yield0.00%
SharesGrow IV$24.79 (+10%)
Analyst Target$25.00 (+10.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
43.5 |
-0.33 |
0.85 |
1.70 |
0.00% |
| 2017 |
5.4 |
0.01 |
0.90 |
1.62 |
0.22% |
| 2018 |
-2.9 |
0.01 |
0.78 |
2.48 |
0.34% |
| 2019 |
4.8 |
-0.03 |
0.68 |
0.99 |
0.28% |
| 2020 |
6.1 |
-0.21 |
0.56 |
1.00 |
0.15% |
| 2021 |
20.8 |
-0.25 |
0.48 |
0.54 |
1.01% |
| 2022 |
-2.4 |
0.00 |
0.46 |
0.44 |
1.69% |
| 2023 |
5.3 |
-0.03 |
0.75 |
0.70 |
0.84% |
| 2024 |
13.7 |
-0.30 |
1.41 |
1.04 |
0.59% |
| 2025 |
5.5 |
0.02 |
1.03 |
0.80 |
0.63% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.26 |
$708.54M |
$27.64M |
3.9% |
| 2017 |
$2.64 |
$926.71M |
$277.8M |
30% |
| 2018 |
$-3.27 |
$377.51M |
$-317.69M |
-84.2% |
| 2019 |
$2.16 |
$979.07M |
$200.62M |
20.5% |
| 2020 |
$1.53 |
$884.57M |
$143.8M |
16.3% |
| 2021 |
$0.27 |
$2.22B |
$58.1M |
2.6% |
| 2022 |
$-2.41 |
$66M |
$-386M |
-584.8% |
| 2023 |
$1.85 |
$2.74B |
$354.8M |
13% |
| 2024 |
$1.29 |
$2.6B |
$199.9M |
7.7% |
| 2025 |
$3.65 |
$3.21B |
$459.6M |
14.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.55 |
$2.54 – $2.56 |
$3.29B |
$3.27B – $3.31B |
2 |
| 2027 |
$2.78 |
$2.74 – $2.81 |
$3.51B |
$3.48B – $3.53B |
2 |
| 2028 |
$3.10 |
$3.09 – $3.11 |
$3.25B |
$3.23B – $3.26B |
1 |
